By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Sarajevo TimesSarajevo TimesSarajevo Times
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Search
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2022 Foxiz News Network. Ruby Design Company. All Rights Reserved.
Reading: More than 20 million Doses of the AstraZeneca Vaccine have been administered in Europe
Share
Font ResizerAa
Sarajevo TimesSarajevo Times
Font ResizerAa
  • HOME
  • POLITICS
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
  • SPORT
  • ARTS
  • W&N
Search
  • HOME
  • POLITICS
    • BH & EU
  • BUSINESS
  • BH TOURISM
  • INTERVIEWS
    • BH & EU
    • BUSINESS
    • ARTS
  • SPORT
  • ARTS
    • CULTURE
    • ENTERTAINMENT
  • W&N
Follow US
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
© 2012 Sarajevo Times. All rights reserved.
Sarajevo Times > Blog > WORLD NEWS > More than 20 million Doses of the AstraZeneca Vaccine have been administered in Europe
WORLD NEWS

More than 20 million Doses of the AstraZeneca Vaccine have been administered in Europe

Published: March 20, 2021
Share
SHARE

As of 17 March 2021, more than 120 million cases of COVID-19 infections, with more than 2 million deaths, had been reported globally.  Vaccination remains a critical tool to help prevent further illness and death and to control the pandemic.

So far, more than 20 million doses of the AstraZeneca vaccine have been administered in Europe and more than 27 million doses of the Covishield vaccine (AstraZeneca vaccine by Serum Institute of India) have been administered in India. 

The GACVS COVID-19 subcommittee met virtually on 16 and 19 March 2021 to review available information and data on thromboembolic events (blood clots) and thrombocytopenia (low platelets) after vaccination with the AstraZeneca COVID-19 vaccine.

The subcommittee reviewed clinical trial data and reports based on safety data from Europe, the United Kingdom, India, and Vigibase, the WHO global database of individual case safety reports.

Based on a careful scientific review of the available information, the subcommittee came to the following conclusions and recommendations: the AstraZeneca COVID-19 vaccine (including Covishield) continues to have a positive benefit-risk profile, with tremendous potential to prevent infections and reduce deaths across the world.

The available data do not suggest any overall increase in clotting conditions such as deep venous thrombosis or pulmonary embolism following administration of COVID-19 vaccines. Reported rates of thromboembolic events after COVID-19 vaccines are in line with the expected number of diagnoses of these conditions. Both conditions occur naturally and are not uncommon. They also occur as a result of COVID-19.  The observed rates have been fewer than expected for such events.

While very rare and unique thromboembolic events in combination with thrombocytopenia, such as cerebral venous sinus thrombosis (CVST), have also been reported following vaccination with the AstraZeneca COVID-19 vaccine in Europe, it is not certain that they have been caused by vaccination. The European Medicines Agency’s Pharmacovigilance and Risk Assessment Committee has reviewed 18 cases of CVST out of a total of more than 20 million vaccinations with the AstraZeneca COVID-19 vaccine in Europe. A causal relationship between these rare events has not been established at this time[1]. 

Trump Tariffs Hit Antarctic Islands Inhabited by Zero Humans and Many Penguins
What is the Amount of Income of the Football Federation of BiH?
Historical-Legal Analysis: The Right of BiH to the Sea?
Pink Shirt Day marked in Sarajevo, sending a Message that Violence needs to be prevented
Diary of a Girl from Zenica: What does it look like to be a Volunteer in Taiwan?
TAGGED:#astrazeneca#BiH#news#vaccine#world
Share This Article
Facebook Whatsapp Whatsapp Telegram Threads Bluesky Email Print
Share
What do you think?
Love0
Sad0
Happy0
Sleepy0
Angry0
Dead0
Wink0
Previous Article Teams of Volunteers to provide Assistance to Elderly in Sarajevo
Next Article When is expected for Bosnia to start Exporting Milk to China?
Leave a Comment Leave a Comment

Leave a Reply Cancel reply

You must be logged in to post a comment.

Stay Connected

10.2KFollowersLike
10.1KFollowersFollow
414FollowersFollow

Latest News

RCC Survey: Western Balkan Citizens worried about cost of Living and Inflation
November 19, 2026
Inspiring Young People to Explore Their Future, EUFOR at Open Day in Brcko
November 19, 2026
Sarajevo hosts the International Logistics Conference with over 250 Participants
November 19, 2026
Pronouncement of the Verdict for Murder of Sarajevo Policemen scheduled
November 19, 2026
BiH Army Colonel Amer Rikovic awarded Prestigious Senior Lecturer Title at NATO School
November 19, 2026
The SDS withdrew its candidacy for the House of Peoples of the Parliamentary Assembly of BiH
November 19, 2026
Bosnia and Herzegovina Still Lacks National Cybersecurity Strategy, Experts Warn of Risks
November 19, 2026
Minimum Wage Negotiations: Take Care of the Worker, but also the Employers
November 19, 2026
Meeting of the Strategic Committee for Weapons, Ammunition, and Mine-Explosive Ordnance Held
November 18, 2026
Becirovic meets the Ambassador of the Republic of Italy Sarah Eti Castellani
November 18, 2026
Sarajevo TimesSarajevo Times
Follow US
© 2012 Sarajevo Times. All Rights Reserved.
  • ABOUT US
  • IMPRESSUM
  • NEWSLETTER
  • CONTACT
Go to mobile version
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?